Comparison of the diagnostic accuracy of whole‐body MRI and whole‐body CT in stage III/IV malignant melanoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1610-0387.2011.07614.xPMID 21352483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?

  2011cited by this paper
• The uses and limitations of whole-body magnetic resonance imaging.

  2010cited by this paper
• Utility of FDG PET/CT and Brain MRI in Melanoma Patients with Increased Serum S-100B Level During Follow-up

  2010cited by this paper
• Overdiagnosis in cancer.

  2010cited by this paper
• omparative study of two whole-body imaging techniques in the case of elanoma metastases : Advantages of multi-contrast MRI examination ncluding a diffusion-weighted sequence in comparison with PET-CT

  2010cited by this paper
• Melanoma staging: facts and controversies.

  2010cited by this paper
• Whole-body MR imaging versus sequential multimodal diagnostic algorithm for staging patients with rectal cancer: cost analysis.

  2010cited by this paper
• Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy

  2009cited by this paper
• Melanoma epidemiology and trends.

  2009cited by this paper
• Whole-body MRI for the staging and follow-up of patients with metastasis.

  2009cited by this paper
• Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.

  2008cited by this paper
• Short German guidelines: Malignant melanoma

  2008cited by this paper
• [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

  2008cited by this paper
• MRI of pulmonary nodules: technique and diagnostic value

  2008cited by this paper
• Kostenüberlegungen zur Ganzkörper-MRT und PET-CT im Rahmen des onkologischen Stagings

  2008cited by this paper
• FDG PET in lymphoma: The need for standardization of interpretation. An observer variation study

  2007cited by this paper
• Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact

  2007cited by this paper
• Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.

  2006cited by this paper
• Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors.

  2006cited by this paper
• Organized breast screening programs in Canada: effect of radiologist reading volumes on outcomes.

  2006cited by this paper
• Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.

  2005cited by this paper
• Breast cancer screening in Canada: a review.

  2005cited by this paper
• Minimization—reducing predictability for multi‐centre trials whilst retaining balance within centre

  2005cited by this paper
• Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.

  2005cited by this paper
• [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].

  2004cited by this paper
• HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT.

  2004cited by this paper
• Ganzkörper-MRT vs. Skelettszintigraphie bei der Detektion ossärer Metastasen solider Tumoren

  2004cited by this paper
• Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society

  2004cited by this paper
• Bildgebende Diagnose und Differenzialdiagnose von Lungenmetastasen

  2004cited by this paper
• [Radiological diagnosis of pulmonary metastases: imaging findings and diagnostic accuracy].

  2004cited by this paper
• Assessment methodologies and statistical issues for computer-aided diagnosis of lung nodules in computed tomography: contemporary research topics relevant to the lung image database consortium.

  2004cited by this paper
• Computerized scheme for determination of the likelihood measure of malignancy for pulmonary nodules on low-dose CT images.

  2003cited by this paper
• Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase.

  2002cited by this paper
• Management of brain metastases

  2002cited by this paper
• Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.

  2001cited by this paper
• Evaluation of the Liver for Metastatic Disease

  2001cited by this paper
• Contrast-enhanced MRI of the lung.

  2000cited by this paper
• CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size.

  2000cited by this paper
• Magnetic resonance imaging versus radionuclide scintigraphy for screening in bone metastases.

  2000cited by this paper
• Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.

  1999cited by this paper
• Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.

  1999cited by this paper
• [Value of MRI in diagnosis of focal liver lesions].

  1995cited by this paper
• The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study

  1993cited by this paper
• Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging.

  1991cited by this paper
• [Reliability of sonography in diagnosing liver metastases in breast and bronchial cancer. A retrospective comparison of physical examination, laboratory tests and liver scintigraphy].

  1986cited by this paper
• Die Zuverlässigkeit der Sonographie bei der Diagnostik von Lebermetastasen beim Mamma- und Bronchialkarzinom

  1986cited by this paper

• Magnetic Resonance of Pulmonary Nodules in Oncological Patients: Are We Ready to Replace Chest CT in Detecting Extrathoracic Cancer?

  2025influential citation
• German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – long version of the update 2023

  2023cites this paper
• Lung Nodule Detection With Modern Low-Field MRI (0.55 T) in Comparison to CT

  2023cites this paper
• Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study

  2023cites this paper
• Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus‐19 vaccine‐associated lymphadenopathy

  2023cites this paper
• Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma

  2022cites this paper
• Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study

  2021cites this paper
• Clinical Evaluation of an Abbreviated Contrast-Enhanced Whole-Body MRI for Oncologic Follow-Up Imaging

  2021cites this paper
• 1.5 vs 3 Tesla Magnetic Resonance Imaging

  2021cites this paper
• Posteriores reversibles Enzephalopathie‐Syndrom bei einem Melanompatienten unter Dabrafenib‐ und Trametinib‐Behandlung nach Immuntherapie

  2020cites this paper
• Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review

  2020cites this paper
• Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

  2019cites this paper
• A Network Meta‐Analysis of Short and Long‐Term Efficacy of Targeted Therapy With Single or Double‐Drug Regimens in the Treatment of Stage III/IV Malignant Melanoma Based on 16 Randomized Controlled Trials

  2018cites this paper
• Magnetic resonance imaging for diagnostics of lung diseases

  2018cites this paper
• S3‐Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0

  2017cites this paper
• Short-Term and Long-Term Management of Melanoma

  2017cites this paper
• Influence of 18F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma

  2016cites this paper
• AusPAR Attachment 2 Extract from the Clinical Evaluation Report for Gadobutrol Proprietary Product

  2015cites this paper
• Ganzkörperdiagnostik beim malignen Melanom

  2015cites this paper
• Therapienebenwirkungen und Nachsorge bei malignem Melanom

  2015cites this paper
• [Treatment side effects and follow-up of malignant melanoma].

  2015cites this paper
• Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations

  2014cites this paper
• Diagnostik von Knochenmetastasen heute und morgen

  2014cites this paper
• MR-PET in Breast Cancer

  2014cites this paper
• MRI of pulmonary nodules.

  2014cites this paper
• S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version

  2013cites this paper
• Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?

  2013cites this paper
• Malignes Melanom S3‐Leitlinie “Diagnostik, Therapie und Nachsorge des Melanoms”

  2013cites this paper
• Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

  2013cites this paper
• Hepatic hemangioma and hemochromatosis misdiagnosed by MRI as metastatic melanoma

  2011cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper